CD73-TNAP crosstalk regulates the hypertrophic response and cardiomyocyte calcification due to α1 adrenoceptor activation

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2014-06-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11010-014-2100-9PMID 24894822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of CD73, equilibrative nucleoside transporters and inosine in rhythm and conduction disturbances mediated by adenosine A1 and A2A receptors in the developing heart.

  2013cited by this paper
• Adenosine as an Endogenous Adaptive Cardiac Antihypertrophic and Antiremodelling Factor

  2013cited by this paper
• Cardiomyocyte calcineurin signaling in subcellular domains: from the sarcolemma to the nucleus and beyond.

  2012cited by this paper
• Intramyocardial calcification in a patient with apical hypertrophic cardiomyopathy.

  2012cited by this paper
• Porcelain Heart: Rapid Progression of Cardiac Calcification in a Patient with Hemodialysis

  2012cited by this paper
• Characterization of Different Subpopulations from Bone Marrow-Derived Mesenchymal Stromal Cells by Alkaline Phosphatase Expression

  2012cited by this paper
• Massive Calcification in the Myocardium Post Infarction

  2012cited by this paper
• Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum.

  2011cited by this paper
• NT5E mutations and arterial calcifications.

  2011cited by this paper
• Targeting of adenosine receptors in ischemia–reperfusion injury

  2011cited by this paper
• NT5E mutations and arterial calcifications.

  2011cited by this paper
• Sepsis-related myocardial calcification.

  2011cited by this paper
• Compensatory upregulation of the adenosine system following phenylephrine-induced hypertrophy in cultured rat ventricular myocytes.

  2010cited by this paper
• Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases.

  2009cited by this paper
• Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality

  2009cited by this paper
• Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).

  2009cited by this paper
• Ecto-5′-Nucleotidase Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction

  2008cited by this paper
• Mechanisms of arterial calcification: spotlight on the inhibitors.

  2008cited by this paper
• Role for alkaline phosphatase as an inducer of vascular calcification in renal failure?

  2008cited by this paper
• Activation of ecto-5'-nucleotidase in the blood and hearts of patients with chronic heart failure.

  2008cited by this paper
• Combined Deficiency of Dystrophin and &bgr;1 Integrin in the Cardiac Myocyte Causes Myocardial Dysfunction, Fibrosis and Calcification

  2008cited by this paper
• Characterization of rat heart alkaline phosphatase isoenzymes and modulation of activity.

  2008cited by this paper
• Alkaline Phosphatases

  2006cited by this paper
• Physiological roles for ecto-5’-nucleotidase (CD73)

  2006cited by this paper
• Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes

  2006cited by this paper
• Inhibition of Phenylephrine-Induced Cardiomyocyte Hypertrophy by Activation of Multiple Adenosine Receptor Subtypes

  2005cited by this paper
• The concentrative nucleoside transporter family, SLC28

  2004cited by this paper
• Activation of Adenosine A1 Receptor Attenuates Cardiac Hypertrophy and Prevents Heart Failure in Murine Left Ventricular Pressure-Overload Model

  2003cited by this paper
• Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization

  2002cited by this paper
• Apoptosis Regulates Human Vascular Calcification In Vitro: Evidence for Initiation of Vascular Calcification by Apoptotic Bodies

  2000cited by this paper
• Contribution of cytosolic and membrane-bound 5'-nucleotidases to cardiac adenosine production.

  1996cited by this paper
• Biology of human alkaline phosphatases with special reference to cancer.

  1995cited by this paper
• Localization of adenosine deaminase and adenosine deaminase complexing protein in rabbit heart. Implications for adenosine metabolism.

  1990cited by this paper
• 5'-Nucleotidase from rat heart.

  1981cited by this paper

• Purinergic ecto-enzymes in human and ovine aortic valves: indicators of bacterial nanocellulose scaffold cellularization

  2025cites this paper
• The synergism of cytosolic acidosis and reduced NAD+/NADH ratio is responsible for lactic acidosis-induced vascular smooth muscle cell impairment in sepsis

  2024cites this paper
• Transcription Factors in Cardiac Remodeling: Latest Advances

  2024cites this paper
• α1‐Adrenoceptors activate the NLRP3 inflammasome through downregulation of Kir2.1 in cardiac inflammation

  2022cites this paper
• Impact of Homoarginine on Myocardial Function and Remodeling in a Rat Model of Chronic Renal Failure

  2022cites this paper
• Expression and Regulation of CD73 during the Estrous Cycle in Mouse Uterus

  2021cites this paper
• The new insight into extracellular NAD+ degradation‐the contribution of CD38 and CD73 in calcific aortic valve disease

  2021cites this paper
• Induction of cardiomyocyte calcification is dependent on FoxO1/NFATc3/Runx2 signaling

  2021cites this paper
• Metabolomic profiling of metoprolol-induced cardioprotection in a murine model of acute myocardial ischemia.

  2020cites this paper
• CD73 or CD39 deletion reveals different mechanisms of formation for spontaneous and mechanically-stimulated adenosine release and sex specific compensations in ATP degradation.

  2020cites this paper
• Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).

  2019cites this paper
• Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation

  2019cites this paper
• TNAP limits TGF-β-dependent cardiac and skeletal muscle fibrosis by inactivating the SMAD2/3 transcription factors

  2019cites this paper
• Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease

  2019cites this paper
• Stellate ganglion block ameliorates vascular calcification by inhibiting endoplasmic reticulum stress

  2018cites this paper
• Extracellular Adenine Nucleotide and Adenosine Metabolism in Calcific Aortic Valve Disease

  2018cites this paper
• Enzymes of the purinergic signaling system exhibit diverse effects on the degeneration of valvular interstitial cells in a 3‐D microenvironment

  2018cites this paper
• Deletion of CD73 in mice leads to aortic valve dysfunction.

  2017cites this paper
• Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC

  2016cites this paper
• The role of ecto-5′-nucleotidase in endothelial dysfunction and vascular pathologies

  2015cites this paper
• TNAP: a new player in cardiac fibrosis? Focus on "Tissue-nonspecific alkaline phosphatase as a target of sFRP2 in cardiac fibroblasts".

  2015cites this paper
• Calcification of joints and arteries: second report with novel NT5E mutations and expansion of the phenotype

  2015cites this paper
• Regulation of Hepatic Drug Metabolizing Enzymes in Chronic Kidney Disease

  2015cites this paper
• Deciphering Ectopic Calcification: Contribution of the Rare, Inherited Disorder Pseudoxanthoma Elasticum

  2015cites this paper
• Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities

  2014cites this paper